-+ 0.00%
-+ 0.00%
-+ 0.00%

RA Capital Management buys Hemab Therapeutics shares worth $120,000

PUBT·05/21/2026 20:21:00
Listen to the news
RA Capital Management buys Hemab Therapeutics shares worth $120,000
  • RA Capital Management, a 10% owner of Hemab Therapeutics Holdings, reported open-market purchases of 4,798 common shares at weighted average prices of $24.97 and $24.94.
  • The RA Capital Healthcare Fund holding rose to 6,376,968 shares.
  • Separate RA Capital-controlled positions disclosed alongside the filing included 1,009,052 shares held by Nexus Fund II, 354,938 shares held by Nexus Fund IV.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hemab Therapeutics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000521), on May 21, 2026, and is solely responsible for the information contained therein.